Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 13.468% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCCC(c1nnnn1CCOC)N1CCN(C(=O)c2ccco2)CC1.Cl
b.) O=C1NC(c2cccc([N+](=O)[O-])c2)Oc2ccccc21
c.) Cc1ccc(Cl)cc1N(CC(=O)NC(C)c1ccccc1)S(C)(=O)=O
Answer: c. Cc1ccc(Cl)cc1N(CC(=O)NC(C)c1ccccc1)S(C)(=O)=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(Cl)cc1N(CC(=O)NC(C)c1ccccc1)S(C)(=O)=O
Cc1ccc(Cl)cc1N(CC(=O)NC(C)c1ccccc1)S(C)(=O)=O
2-(5-chloro-2-methyl-N-methylsulfonylanilino)-N-(1-phenylethyl)acetamide